Science AI Journal
Medicine · Research topic

Open research questions in Cutaneous lymphoproliferative disorders research

177 gap statements mined from Cutaneous lymphoproliferative disorders research papers in our 7.9M-paper local library, which holds 913 papers on the topic — drawn mostly from each paper's own stated research gap, future-work, challenge and limitation notes, and its abstract. The ones listed below are a selection still marked open; each names the study that raised it, with a DOI link where the paper has one.

Choosing where to publish on Cutaneous lymphoproliferative disorders research? See the ranked Medicine journals.

What the literature leaves open

  • Given these advantages, non-invasive imaging techniques may play an important complementary role in the management of MF, and further research in this field is warranted.

    Non-Invasive Skin Imaging Techniques for Diagnosing and Monitoring Mycosis Fungoides: A Comprehensive Review · 2026 · DOI

  • To overcome the main limitations of earlier studies, such as small sample sizes and publication bias, future research should involve multicenter studies with standardized imaging protocols. These approaches would enhance the generalizability and reproducibility of imaging findings. It is also important to compare different imaging methods directly in the same group of patients.

    Non-Invasive Skin Imaging Techniques for Diagnosing and Monitoring Mycosis Fungoides: A Comprehensive Review · 2026 · DOI

  • Missing data and the need for statistical imputation or complete-case elimination.

    Real-world cardiovascular safety profile of bexarotene for the treatment of mycosis fungoides · 2026 · DOI

  • Advanced-stage cutaneous T-cell lymphomas (CTCL) typically manifest as either skin tumor formation or erythroderma; however, exact mechanisms of lesion formation remain insufficiently characterized.

    0128 Advanced-stage cutaneous T-cell lymphomas show distinct immune profiles in erythroderma vs. tumor lesions · 2025 · DOI

  • Despite all efforts to identify an infectious agent of either bacterial or viral origin that might be involved in CTCL development, the trigger of this malignancy remains unclear. The recently discovered human cutaviruses emerged as sound candidates with etiopathogenic roles in this disease.

    The Complex Role of Infectious Agents in Human Cutaneous T-Cell Lymphoma Pathogenesis: From Candidate Etiological Factors to Potential Therapeutics · 2024 · DOI

  • Mycosis fungoides (MF) and Sézary syndrome (SS) are rare cutaneous lymphomas with limited data on psychological burden.

    Psychological Distress, Symptom Burden and Quality of Life in Patients with Mycosis Fungoides and Sézary Syndrome · 2026 · DOI

  • As the current literature is scarce and shows mixed results this study investigates the incidence of other primary malignancies in mycosis fungoides patients.

    Mycosis Fungoides and Associated Malignancies in a Dutch Nationwide Retrospective Cohort Study · 2024 · DOI

  • In the 5th edition of the WHO classification, TFH lymphoma is limited to lymph node and there is no consensus regarding the management of extranodal TFH lymphoma.

    A Case of Primary Cutaneous T‐Follicular Helper Cell Lymphoma, Follicular‐Type · 2025 · DOI

  • Mycosis fungoides (MF), Sézary syndrome (SS) and other cutaneous T-cell lymphomas (CTCLs) can have a severe impact on quality of life (QoL) and itch, but early MF is insufficiently investigated despite representing most patients.

    Identification of subgroups of early-stage mycosis fungoides patients with increased itch and impaired quality of life · 2025 · DOI

  • Further research into optimizing TSEBT and exploring combinations with systemic treatments is ongoing.

    Total skin electron beam therapy · 2025 · DOI

  • There have been several reports of dupilumab use and the development of CTCL; however, the risk of CTCL development has not been adequately evaluated at the population level.

    Increased Risk of Cutaneous T‐Cell Lymphoma Development after Dupilumab Use for Atopic Dermatitis · 2024 · DOI

  • This study addresses the gap in research comparing the effectiveness between home and in-office narrowband ultraviolet B (NB-UVB) phototherapy for the treatment of mycosis fungoides (MF).

    A Retrospective Comparison Between Home and in‐Office NB ‐ UVB Efficacy for Patients With Mycosis Fungoides · 2024 · DOI

  • Further clinical research on the mechanism of action of immune checkpoint inhibitors (ICI) in cutaneous T-cell lymphoma (CTCL) is needed. Studies on the long-term effectiveness of the combination of ipilimumab and nivolumab in Sézary syndrome are needed.

    Erfolgreiche Checkpointinhibition plus extrakorporale Photopherese bei einem Patienten mit metastasiertem Melanom und fortgeschrittenem Sézary-Syndrom · 2026 · DOI

  • The diagnosis of PTCL-NOS is challenging due to the lack of specific classification criteria and nonspecific clinical features. The treatment of PTCL-NOS with secondary cutaneous involvement is challenging due to the poor response to conventional chemotherapy. The analysis of scRNA-seq data is challenging due to the complexity of the data.

    Case Report: Cutaneous niche-restricted malignant phenotypes in PTCL-NOS revealed by single-cell sequencing · 2026 · DOI

  • The study is limited to a single patient. Normal skin tissue was not biopsied due to ethical constraints and the patient's near-total body surface involvement. The study did not investigate the long-term outcomes of the patient.

    Case Report: Cutaneous niche-restricted malignant phenotypes in PTCL-NOS revealed by single-cell sequencing · 2026 · DOI

  • CTCL is a heterogeneous group of lymphoproliferative disorders. The cause of CTCL is not known. Limited literature is available on the Indian population where total skin electron beam therapy was given.

    Outcome of Cutaneous T-cell Lymphoma with Total Skin Electron Beam Therapy (TSEBT)-A Single Institute Retrospective Study from India · 2026 · DOI

  • The lack of a formal systematic search strategy may have resulted in the omission of certain relevant studies. The analysis of genomic alterations and tumor microenvironment impact requires specialized expertise.

    Established and emerging prognostic factors in mycosis fungoides and Sézary syndrome · 2026 · DOI

  • Inclusion of patients with PCHM in the analysis of the overall frontline group did not notably affect response rates (CR 1 CRc of 70%) or OS, representing meaningful outcomes for this understudied group of patients.

    Pivekimab Sunirine in Blastic Plasmacytoid Dendritic Cell Neoplasm · 2026 · DOI

  • Due to its rarity, subcutaneous panniculitis-like T-cell lymphoma (SPTCL) is often misdiagnosed as benign panniculitis, and there are no standardized treatment guidelines for SPTCL.

    RETRACTED: Clinical analysis of 10 cases with subcutaneous panniculitis‐like T‐cell lymphoma and tissue AURKA expression · 2024 · DOI

  • Although CD200 expression has been well established in B-cell neoplasms, it has rarely been studied in T-cell neoplasms, particularly by flow cytometry (FCM).

    CD200 expression in CD4 + T‐cells: Diagnostic implications across T‐cell lymphomas · 2025 · DOI

  • Primary cutaneous CD4+ small/medium T‐cell lymphoproliferative disorder (PCSM‐LPD) is a rare lymphoid proliferation whose dermoscopic features are poorly defined, making diagnosis challenging.

    Primary Cutaneous CD4+ Small/Medium T‐Cell Lymphoproliferative Disorder (PCSM‐LPD): Dermoscopic Clues to Address Its Diagnosis and Their Interobserver Reliability · 2025 · DOI

  • Limited access to specialized molecular laboratories and reimbursement constraints. Restricted availability of TCR gene rearrangement testing. The study is based on a survey of dermatologists in Türkiye.

    A Cross-Sectional Study of Mycosis Fungoides Care: Diagnostic Challenges, Therapeutic Accessibility, and Resource-Adapted Solutions · 2026 · DOI

  • Although there is scarce literature reporting on the leading non-cancer CODs in MF and SS patients, when reviewing 1 3Archives of Dermatological Research (2026)…

    Non-cancer causes of death for patients with mycosis fungoides or Sézary syndrome from 2000 to 2020: a US population-based analysis of SEER patient data · 2026 · DOI

  • Further studies to evaluate the long-term cardiovascular safety of bexarotene, - Investigations into the mechanisms underlying the metabolic and endocrine effects of bexarotene, - Research into the potential consequences of bexarotene-induced metabolic and endocrine…

    Real-world cardiovascular safety profile of bexarotene for the treatment of mycosis fungoides · 2026 · DOI

  • Implementation and evaluation of the proposed four-component plan. Development of standardized workflows and algorithm-based approaches. Investigation of strategies to improve access to advanced diagnostic tools and therapies.

    A Cross-Sectional Study of Mycosis Fungoides Care: Diagnostic Challenges, Therapeutic Accessibility, and Resource-Adapted Solutions · 2026 · DOI

Most-cited papers in Cutaneous lymphoproliferative disorders research

Most recent work

Find a gap in your own Cutaneous lymphoproliferative disorders research sub-topic

This page shows what the Cutaneous lymphoproliferative disorders research literature already flags as unresolved. To narrow it to your specific question, search the Research Gap Finder: the search is free with a free account and lists the papers closest to your topic first. Unlocking that topic (50 credits, charged once) fills the comparison table from our 7.9M-paper local library and writes the gaps from its rows.

Open the Research Gap Finder →

Related topics in Medicine

Artificial Intelligence in Healthcare and Education
4,869 open questions
Dementia and Cognitive Impairment Research
3,297 open questions
Cancer Immunotherapy and Biomarkers
2,687 open questions
Liver Disease Diagnosis and Treatment
2,481 open questions
Substance Abuse Treatment and Outcomes
2,366 open questions
Sports Performance and Training
2,276 open questions
Mosquito-borne diseases and control
2,124 open questions
Parkinson's Disease Mechanisms and Treatments
2,117 open questions
Open questions raised by papers listed on this page include: (1) Given these advantages, non-invasive imaging techniques may play an important complementary role in the management of MF, and further research in this field is warranted (“Non-Invasive Skin Imaging Techniques for Diagnosing and Monitoring Mycosis…”, 2026); (2) Further clinical research on the mechanism of action of immune checkpoint inhibitors (ICI) in cutaneous T-cell lymphoma (CTCL) is needed (“Erfolgreiche Checkpointinhibition plus extrakorporale Photopherese bei einem…”, 2026); (3) The diagnosis of PTCL-NOS is challenging due to the lack of specific classification criteria and nonspecific clinical features (“Case Report: Cutaneous niche-restricted malignant phenotypes in PTCL-NOS…”, 2026); (4) The lack of a formal systematic search strategy may have resulted in the omission of certain relevant studies (“Established and emerging prognostic factors in mycosis fungoides and Sézary…”, 2026); (5) Advanced-stage cutaneous T-cell lymphomas (CTCL) typically manifest as either skin tumor formation or erythroderma; however, exact mechanisms of lesion formation remain insufficiently characterized (“0128 Advanced-stage cutaneous T-cell lymphomas show distinct immune profiles in…”, 2025). 177 gap statements have been mined from Cutaneous lymphoproliferative disorders research papers in our 7.9M-paper local library, which holds 913 papers on the topic; the gaps come from whichever of those papers state one. They are mostly the research gaps the authors state and the papers' abstracts, plus future-work, limitations and challenges passages. The ones listed below are a selection still marked open; each names the study that raised it, with a DOI link where the paper has one, so you can read the original claim in context.

Tools for your next paper

Gaps & Literature SearchFind open questions in any field — 1,100,000+ open gaps mined from our own library.Pre-CheckIs your paper ready? Acceptance odds for top, mid and open/emerging journals, in seconds.Journal FinderA ranked shortlist of target journals from a 17,500-venue index.Duplicate Publication CheckerCheck for prior publication across 7 sources and our local library.Citation GeneratorFreeA DOI or title → APA, MLA, Vancouver, Chicago, BibTeX, RIS. No signup.Graphical Abstract MakerFreeTurn your findings into a colorblind-safe graphical abstract.

How Pre-Check worksHow AI Review works

Compare the category — Honest roundups of the AI research tools, ours listed alongside the alternatives.

Command palette

Jump anywhere, run any action.